Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/51040
Full metadata record
DC FieldValueLanguage
dc.contributor.authorK. Makonkawkeyoonen_US
dc.contributor.authorT. Sudjaritruken_US
dc.contributor.authorV. Sirisanthanaen_US
dc.contributor.authorS. Silvilairaten_US
dc.date.accessioned2018-09-04T04:50:35Z-
dc.date.available2018-09-04T04:50:35Z-
dc.date.issued2010-09-01en_US
dc.identifier.issn14653281en_US
dc.identifier.issn02724936en_US
dc.identifier.other2-s2.0-77956433110en_US
dc.identifier.other10.1179/146532810X12703902516446en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77956433110&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/51040-
dc.description.abstractA previously healthy 3-year-old boy presented with high-grade fever, dyspnoea, alteration of consciousness, tachycardia and shock. A few erythematous macules and papules were seen on his palms and soles. Echocardiogram showed poor left ventricular contraction. Cardiac enzymes and pro-B-type natriuretic peptide were elevated. Milrinone, low-dose dopamine and intravenous immunoglobulin were administered. The patient recovered after 5 days without cardiac or neurological sequelae. The serological results showed a four-fold rise of enterovirus 71. In children with severe EV71 infection, early recognition of cardiopulmonary involvement and aggressive treatment are crucial to successful management. © 2010 Maney.en_US
dc.subjectMedicineen_US
dc.titleFulminant enterovirus 71 infection: Case reporten_US
dc.typeJournalen_US
article.title.sourcetitleAnnals of Tropical Paediatricsen_US
article.volume30en_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.